Skip to main content
Erschienen in: Clinical Rheumatology 4/2005

01.08.2005 | Original Article

Oesophageal manometry in early and definite systemic sclerosis

verfasst von: Paolo Airò, Domenico Della Casa, Elisabetta Danieli, Guido Missale, Roberto Cattaneo, Renzo Cestari

Erschienen in: Clinical Rheumatology | Ausgabe 4/2005

Einloggen, um Zugang zu erhalten

Abstract

The objective of this study was to evaluate the oesophageal dysfunction in patients with “early” systemic sclerosis (SSc), as defined by LeRoy and Medsger, to compare it with that of patients with definite SSc, and to correlate it with other features of the disease. Oesophageal manometry results were retrospectively evaluated in 181 patients classified by the 2001 LeRoy and Medsger criteria and the 1980 American College of Rheumatology (ACR) criteria: group 1: limited SSc: Raynaud’s phenomenon plus specific nailfold capillaroscopy abnormalities and/or autoantibodies; group 2: limited cutaneous SSc not satisfying the ACR criteria (lcSSc ACR−); group 3: lcSSc ACR+; group 4: diffuse cutaneous SSc. Peristaltic abnormalities in the oesophageal body were present in 73 of 125 patients with SSc ACR+ (groups 3 and 4) compared with 13 of 56 with SSc ACR− (groups 1 and 2) (p<0.0001). They were more severe in patients with more advanced disease (1 vs 2; 1 vs 3; 1 vs 4; 2 vs 4; p<0.05) and in patients anti-Scl-70+ than in patients anticentromere positive (p=0.02). Abnormalities of the lower oesophageal sphincter (LES) were present in 35 of 125 patients with SSc ACR+ and 11 of 56 with SSc ACR− (not statistically different). They were correlated with forced vital capacity (FVC) (LES pressure: p=0.0005; LES length: p=0.0004). Abnormalities of the oesophageal body and of the LES were found in 21 and 16% of 46 patients without oesophageal symptoms. Oesophageal manometry can detect abnormalities in a sizeable proportion of patients with “early SSc” not fulfilling the ACR criteria, including asymptomatic patients. The correlation between LES abnormalities and FVC suggests a possible causal relationship between these disease manifestations.
Literatur
1.
Zurück zum Zitat Sjoegren R (1994) Gastrointestinal motility disorders in systemic sclerosis. Arthritis Rheum 37:1265–1282PubMed Sjoegren R (1994) Gastrointestinal motility disorders in systemic sclerosis. Arthritis Rheum 37:1265–1282PubMed
2.
Zurück zum Zitat Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis. Arthritis Rheum 23:581–590 Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis. Arthritis Rheum 23:581–590
3.
Zurück zum Zitat Kallenberg CGM, Wouda AA, Hoet HM, van Venroij WJ (1988) Development of connective tissue disease in patients presenting with Raynaud’s phenomenon: a six-year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting. Ann Rheum Dis 47:634–641PubMed Kallenberg CGM, Wouda AA, Hoet HM, van Venroij WJ (1988) Development of connective tissue disease in patients presenting with Raynaud’s phenomenon: a six-year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting. Ann Rheum Dis 47:634–641PubMed
4.
Zurück zum Zitat Weiner ES, Hildebrandt S, Senecal JL et al (1991) Prognostic significance of anticentromere antibodies and anti-topoisomerase I antibodies in Raynaud’s disease. A prospective study. Arthritis Rheum 34:68–77PubMed Weiner ES, Hildebrandt S, Senecal JL et al (1991) Prognostic significance of anticentromere antibodies and anti-topoisomerase I antibodies in Raynaud’s disease. A prospective study. Arthritis Rheum 34:68–77PubMed
5.
Zurück zum Zitat Medsger TA Jr (1985) Comment on scleroderma criteria cooperative study. In: Black CM, Myers AR (eds) Current topics in rheumatology: systemic sclerosis (scleroderma). Gower Medical Publishing, New York, pp 16–17 Medsger TA Jr (1985) Comment on scleroderma criteria cooperative study. In: Black CM, Myers AR (eds) Current topics in rheumatology: systemic sclerosis (scleroderma). Gower Medical Publishing, New York, pp 16–17
6.
Zurück zum Zitat Scussel-Lonzetti L, Joyal F, Raynauld JP et al (2001) Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 44:735–736PubMed Scussel-Lonzetti L, Joyal F, Raynauld JP et al (2001) Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 44:735–736PubMed
7.
Zurück zum Zitat LeRoy EC, Medsger TA Jr (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28:1573–1576PubMed LeRoy EC, Medsger TA Jr (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28:1573–1576PubMed
8.
Zurück zum Zitat Wigley FM (2001) When is scleroderma really scleroderma? J Rheumatol 28:1471–1473PubMed Wigley FM (2001) When is scleroderma really scleroderma? J Rheumatol 28:1471–1473PubMed
9.
Zurück zum Zitat LeRoy EC, Black C, Fleischmayer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–208PubMed LeRoy EC, Black C, Fleischmayer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–208PubMed
10.
Zurück zum Zitat Maricq HR (1981) Wide-field capillary microscopy: technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthritis Rheum 24:1159–1165PubMed Maricq HR (1981) Wide-field capillary microscopy: technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthritis Rheum 24:1159–1165PubMed
11.
Zurück zum Zitat Maricq HR, Harper FE, Khan EM, Tan EM, LeRoy EC (1983) Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease. Clin Exp Rheumatol 1:195–205PubMed Maricq HR, Harper FE, Khan EM, Tan EM, LeRoy EC (1983) Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease. Clin Exp Rheumatol 1:195–205PubMed
12.
Zurück zum Zitat Bernstein RM, Bunn CC, Hughes GRV (1982) Identification of antibodies to acidic antigens by counterimmunoelectrophoresis. Ann Rheum Dis 41:554–555PubMed Bernstein RM, Bunn CC, Hughes GRV (1982) Identification of antibodies to acidic antigens by counterimmunoelectrophoresis. Ann Rheum Dis 41:554–555PubMed
13.
Zurück zum Zitat Pope CE II (1992) The quality of life following antireflux surgery. World J Surg 16:335–358PubMed Pope CE II (1992) The quality of life following antireflux surgery. World J Surg 16:335–358PubMed
14.
Zurück zum Zitat Henry MACA, Harbermann MC, Rocha OM (1999) Esophageal motor disturbance in progressive systemic sclerosis. Dis Esophagus 12:51–53PubMed Henry MACA, Harbermann MC, Rocha OM (1999) Esophageal motor disturbance in progressive systemic sclerosis. Dis Esophagus 12:51–53PubMed
15.
Zurück zum Zitat Dodds WJ, Hogan WJ, Steff JJ, Miller WN, Arndorfer RC (1975) A rapid pull-through technique for measuring lower esophageal sphincter pressure. Gastroenterology 68:437–443PubMed Dodds WJ, Hogan WJ, Steff JJ, Miller WN, Arndorfer RC (1975) A rapid pull-through technique for measuring lower esophageal sphincter pressure. Gastroenterology 68:437–443PubMed
16.
Zurück zum Zitat Bassotti G, Bacci G, Biagini D, David P, Alunni G, Pelli MA (1988) Manometric evaluation of the entire esophagus in healthy subjects and patients with high amplitude peristaltic contractions. Dysphagia 3:93–96PubMed Bassotti G, Bacci G, Biagini D, David P, Alunni G, Pelli MA (1988) Manometric evaluation of the entire esophagus in healthy subjects and patients with high amplitude peristaltic contractions. Dysphagia 3:93–96PubMed
17.
Zurück zum Zitat Winans CS, Harris LD (1967) Quantitation of lower esophageal sphincter competence. Gastroenterology 52:773–778PubMed Winans CS, Harris LD (1967) Quantitation of lower esophageal sphincter competence. Gastroenterology 52:773–778PubMed
18.
Zurück zum Zitat Castell JA (1987) The computer in the motility laboratory. In: Castell DO, Richetr JE, Dalton CB (eds) Esophageal motility testing. Elsevier, New York Castell JA (1987) The computer in the motility laboratory. In: Castell DO, Richetr JE, Dalton CB (eds) Esophageal motility testing. Elsevier, New York
19.
Zurück zum Zitat Doria A, Bonavina L, Anselmino M et al (1991) Esophageal involvement in mixed connective tissue disease. J Rheumatol 18:685–690PubMed Doria A, Bonavina L, Anselmino M et al (1991) Esophageal involvement in mixed connective tissue disease. J Rheumatol 18:685–690PubMed
20.
Zurück zum Zitat Orlowski J, Dodds WJ, Linehan JH, Dent J, Hogan WJ, Amdorfer RC (1982) Requirements for accurate manometric recording of pharyngeal and esophageal peristaltic pressure waves. Invest Radiol 17:567–572PubMed Orlowski J, Dodds WJ, Linehan JH, Dent J, Hogan WJ, Amdorfer RC (1982) Requirements for accurate manometric recording of pharyngeal and esophageal peristaltic pressure waves. Invest Radiol 17:567–572PubMed
21.
Zurück zum Zitat Richter JE, Wu WC, Johns DN et al (1987) Esophageal manometry in 95 healthy adult volunteers. Dig Dis Sci 32:583–592PubMed Richter JE, Wu WC, Johns DN et al (1987) Esophageal manometry in 95 healthy adult volunteers. Dig Dis Sci 32:583–592PubMed
22.
Zurück zum Zitat Passaretti S, Baldi F, Costantini M, Di Martino N, Leo P, Zaninotto G (2000) Manometria esofagea. Farmaci 24:7–18 Passaretti S, Baldi F, Costantini M, Di Martino N, Leo P, Zaninotto G (2000) Manometria esofagea. Farmaci 24:7–18
23.
Zurück zum Zitat American Gastroenterological Association (1994) Technical review on the clinical use of esophageal manometry. Gastroenterology 107:1865–1884 American Gastroenterological Association (1994) Technical review on the clinical use of esophageal manometry. Gastroenterology 107:1865–1884
24.
Zurück zum Zitat Evans DF, Buckton GK (1999) Clinical measurement in gastroenterology. In: The esophagus. Blackwell Science Ltd, Oxford Evans DF, Buckton GK (1999) Clinical measurement in gastroenterology. In: The esophagus. Blackwell Science Ltd, Oxford
25.
Zurück zum Zitat Cotes JE, Chinn DJ, Roca J, Quanjer PH, Yernault JC (1993) Standardization of the measurement of transfer factor (diffusing capacity). Eur Respir J 16 [Suppl]:41–52 Cotes JE, Chinn DJ, Roca J, Quanjer PH, Yernault JC (1993) Standardization of the measurement of transfer factor (diffusing capacity). Eur Respir J 16 [Suppl]:41–52
26.
Zurück zum Zitat Quanjer PH, Tammerling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC (1994) Lung volumes and forced ventilatory flows. Rev Mal Respir 11:5–40 Quanjer PH, Tammerling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC (1994) Lung volumes and forced ventilatory flows. Rev Mal Respir 11:5–40
27.
Zurück zum Zitat Weihrauch TR, Korting GW (1982) Manometric assessment of oesophageal involvement in progressive systemic sclerosis, morphoea and Raynaud’s disease. Br J Dermatol 107:325–332PubMed Weihrauch TR, Korting GW (1982) Manometric assessment of oesophageal involvement in progressive systemic sclerosis, morphoea and Raynaud’s disease. Br J Dermatol 107:325–332PubMed
28.
Zurück zum Zitat Hamel-Roy J, Devroede G, Arhan P, Tetreault L, Duranceau A, Menard HA (1985) Comparative esophageal and anorectal motility in scleroderma. Gastroenterology 88:1–7PubMed Hamel-Roy J, Devroede G, Arhan P, Tetreault L, Duranceau A, Menard HA (1985) Comparative esophageal and anorectal motility in scleroderma. Gastroenterology 88:1–7PubMed
29.
Zurück zum Zitat Tsianos EB, Drosos AA, Chiras CD, Moutsopulos HM, Kitridou R (1987) Esophageal manometric findings in autoimmune rheumatic diseases: is scleroderma esophagus a specific entity? Rheumatol Int 7:23–27PubMed Tsianos EB, Drosos AA, Chiras CD, Moutsopulos HM, Kitridou R (1987) Esophageal manometric findings in autoimmune rheumatic diseases: is scleroderma esophagus a specific entity? Rheumatol Int 7:23–27PubMed
30.
Zurück zum Zitat Akesson A, Wollheim FA (1989) Organ manifestations in 100 patients with progressive systemic sclerosis: a comparison between CREST syndrome and diffuse scleroderma. Br J Rheumatol 28:281–286PubMed Akesson A, Wollheim FA (1989) Organ manifestations in 100 patients with progressive systemic sclerosis: a comparison between CREST syndrome and diffuse scleroderma. Br J Rheumatol 28:281–286PubMed
31.
Zurück zum Zitat Yarze JC, Varga J, Stampfl D, Castell DO, Jimenez SA (1993) Esophageal function in systemic sclerosis: a prospective evaluation of motility and acid reflux in 36 patients. Am J Gastroenterol 88:870–876PubMed Yarze JC, Varga J, Stampfl D, Castell DO, Jimenez SA (1993) Esophageal function in systemic sclerosis: a prospective evaluation of motility and acid reflux in 36 patients. Am J Gastroenterol 88:870–876PubMed
32.
Zurück zum Zitat Lapadula G, Muolo P, Semeraro F et al (1994) Esophageal dysmotility disorders in the rheumatic diseases: a review of 150 patients. Clin Exp Rheumatol 12:515–521PubMed Lapadula G, Muolo P, Semeraro F et al (1994) Esophageal dysmotility disorders in the rheumatic diseases: a review of 150 patients. Clin Exp Rheumatol 12:515–521PubMed
33.
Zurück zum Zitat Bassotti G, Battaglia E, Debernardi V et al (1997) Esophageal dysfunction in scleroderma. Relationship with disease subsets. Arthritis Rheum 40:2252–2259PubMed Bassotti G, Battaglia E, Debernardi V et al (1997) Esophageal dysfunction in scleroderma. Relationship with disease subsets. Arthritis Rheum 40:2252–2259PubMed
34.
Zurück zum Zitat Krieg T, Meurer M (1988) Systemic scleroderma: clinical and pathophysiologic aspects. J Am Acad Dermatol 18:457–481PubMed Krieg T, Meurer M (1988) Systemic scleroderma: clinical and pathophysiologic aspects. J Am Acad Dermatol 18:457–481PubMed
35.
Zurück zum Zitat Koshino Y, Takai T, Kato T et al (1991) Manometric evaluation of esophageal function in progressive systemic sclerosis with special regard to disease severity. Gastroenterol Jpn 26:575–581PubMed Koshino Y, Takai T, Kato T et al (1991) Manometric evaluation of esophageal function in progressive systemic sclerosis with special regard to disease severity. Gastroenterol Jpn 26:575–581PubMed
36.
Zurück zum Zitat Giordano M, Valentini G, Migliaresi S, Picillo U, Vatti M (1986) Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis. J Rheumatol 13:911–916PubMed Giordano M, Valentini G, Migliaresi S, Picillo U, Vatti M (1986) Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis. J Rheumatol 13:911–916PubMed
37.
Zurück zum Zitat Poormoghim H, Lucas M, Fertig N, Mesdger TA Jr (2000) Systemic sclerosis sine scleroderma. Arthritis Rheum 43:444–451PubMed Poormoghim H, Lucas M, Fertig N, Mesdger TA Jr (2000) Systemic sclerosis sine scleroderma. Arthritis Rheum 43:444–451PubMed
38.
Zurück zum Zitat Hostein J, Bost R, Carpentier P, Franco A, Fornet J (1985) Motricité oesophagienne au cours de la maladie de Raynaud, de la sclérodermie systémique et du syndrome de Raynaud présclérodermique. Gastroenterol Clin Biol 9:130–135PubMed Hostein J, Bost R, Carpentier P, Franco A, Fornet J (1985) Motricité oesophagienne au cours de la maladie de Raynaud, de la sclérodermie systémique et du syndrome de Raynaud présclérodermique. Gastroenterol Clin Biol 9:130–135PubMed
39.
Zurück zum Zitat Kinuya K, Nakajima K, Kinuya S, Michigishi T, Tonami N, Takehara K (2001) Esophageal hypomotility in systemic sclerosis: close relationship with pulmonary involvement. Ann Nucl Med 15:97–101PubMed Kinuya K, Nakajima K, Kinuya S, Michigishi T, Tonami N, Takehara K (2001) Esophageal hypomotility in systemic sclerosis: close relationship with pulmonary involvement. Ann Nucl Med 15:97–101PubMed
40.
Zurück zum Zitat Gonzalez R, Storr M, Bloching H, Seige M, Ott R, Allescher HD (2001) Autoantibody profile in systemic sclerosis as markers for esophageal involvement. J Clin Gastroenterol 32:123–127PubMed Gonzalez R, Storr M, Bloching H, Seige M, Ott R, Allescher HD (2001) Autoantibody profile in systemic sclerosis as markers for esophageal involvement. J Clin Gastroenterol 32:123–127PubMed
41.
Zurück zum Zitat Denis P, Ducrotte P, Pasquis P, Lefrançois R (1981) Esophageal motility and pulmonary function in progressive systemic sclerosis. Respiration 42:21–24PubMed Denis P, Ducrotte P, Pasquis P, Lefrançois R (1981) Esophageal motility and pulmonary function in progressive systemic sclerosis. Respiration 42:21–24PubMed
42.
Zurück zum Zitat Marie I, Dominique S, Levesque H et al (2001) Esophageal involvement and pulmonary manifestations in systemic sclerosis. Arthritis Rheum 45:346–354PubMed Marie I, Dominique S, Levesque H et al (2001) Esophageal involvement and pulmonary manifestations in systemic sclerosis. Arthritis Rheum 45:346–354PubMed
43.
Zurück zum Zitat Troshinsky MB, Kane GC, Varga J et al (1994) Pulmonary function and gastroesophageal reflux in systemic sclerosis. Ann Intern Med 121:6–10PubMed Troshinsky MB, Kane GC, Varga J et al (1994) Pulmonary function and gastroesophageal reflux in systemic sclerosis. Ann Intern Med 121:6–10PubMed
Metadaten
Titel
Oesophageal manometry in early and definite systemic sclerosis
verfasst von
Paolo Airò
Domenico Della Casa
Elisabetta Danieli
Guido Missale
Roberto Cattaneo
Renzo Cestari
Publikationsdatum
01.08.2005
Erschienen in
Clinical Rheumatology / Ausgabe 4/2005
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-004-1049-6

Weitere Artikel der Ausgabe 4/2005

Clinical Rheumatology 4/2005 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.